Influenza vaccination in the elderly

Developmental and Comparative Immunology

Volumn 21, Issue 6, 1997, Pages 501-507

  Glück, Reinhard ^a   Wegmann, Alfred ^a  

^a Berna Biotech AG   (Switzerland)

Author keywords

Elderly; Influenza; Vaccination

Indexed keywords

GLYCOPROTEIN; HEMAGGLUTININ; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; LIVE VACCINE; SIALIDASE;

ANTIBODY TITER; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; PRIORITY JOURNAL; REVIEW; SEROCONVERSION;

EID: 0344074030     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-305X(97)00030-X     Document Type: Article

References (27)

1. Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control (CDC). Prevention and control of influenza. Morb. Mort. Wkly Rep. 1996, 45, RR-5, 1-24.
2. Murphy, B.R., Webster, R.G. Orthomyxoviruses. In Fields virology, 3rd edn, Chapter 46, eds B. N. Fields, D. M. Knipe, P. W. Howley et al. Lipincott-Raven Publishers, Philadelphia, 1996, 1397-1445.
3. Powers, D. G.; Hanscome, P. J.; Pietrobon, P. J. F. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccinates induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine 13:1330-1335; 1995.
4. Glück, R.; Mischler, R.; Finkel, B.; Que, J. U.; Scarpa, B.; Cryz, S. J. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 344:160-163; 1994.
5. Ada, G. L.; Jones, P. D. The immune response to influenza infection. Curr. Topics Microbiol. Immun. 128:1-54; 1986.
6. Davies, J. R.; Grilli, E. A. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol. Infect. 102:325-333; 1989.
7. Hobson, D.; Curry, R. L.; Beare, A. S.; Ward-Gardner, A. The role of serum hemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.) 70:767-777; 1972.
8. Ad hoc CPMP working party on influenza vaccines: Summary Record of the Meeting on the choice of strains for influenza vaccines for the 1995-1996 vaccination campaign, Brussels, 27 February 1995, EMEA.
9. Kuwano, K.; Scott, M.; Young, J. F.; Ennis, F. A. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. J. Immunol. 140:1264-1268; 1988.
10. Lukacher, A. C.; Braciale, V. L.; Braciale, T. J. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Expl. Med. 160:814-826; 1984.
11. Yap, K. L.; Ada, G. L. The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes. Scand. J. Immunol. 7:389-397; 1978.
12. Yap, K. L.; Ada, G. L.; McKenzie, I. F. C. Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273:238-239; 1978.
13. McMichael, A. J.; Gotch, F. M.; Noble, G. R.; Beare, P. A. S. Cytotoxic T cell immunity to influenza. N. Engl. J. Med. 309:13-17; 1983.
14. Gorse, G. J.; Belshe, R. B. Enhanced lympho-proliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses. Scand. J. Infect. Dis. 23:7-17; 1991.
15. Gorse, G. J.; Belshe, R. B. Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older chronically ill adults. J. Clin. Microbiol. 28:2539-2550; 1990.
16. Webster, R. G.; Askonas, B. A. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur. J. Immunol. 10:396-401; 1980.
17. Gorse, G. J.; Campbell, M. J.; Otto, E. E.; Powers, D. C.; Chambers, G. W.; Newman, F. K. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with life attenuated or inactivated influenza virus vaccine. J. Infect. Dis. 172:1-10; 1995.
18. Saurwein-Teissl, M., Steger, M. M., Glück, R., Cryz, S., Grubeck-Loebenstein, B. In vitro studies on the stimulatory effects of a new virosome influenza vaccine on T cells from young and old healthy individuals (in prep).
19. McElhaney, J. E.; Meneilly, G. S.; Lechelt, K. E.; Bleackley, R. C. Split-virus influenza vaccines: Do they provide adequate immunity to the elderly? J. Gerontol. 49:M37-M43; 1994.
20. Beyer, W. E. P.; Palache, A. M.; Baljet, J.; Masurel, N. Antibody induction by influenza vaccines in the elderly: a review of the literature. Vaccine 7:385-394; 1989.
21. McElhaney, J. E.; Meneilly, G. S.; Lechelt, X.; Beattie, B. L.; Bleackley, R. C. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. Vaccine 11:1055-1060; 1993.
22. Edwards, K. M.; Dupont, W. D.; Westrich, M. K.; Plummer, W. D.; Palmer, P. S.; Wright, P. F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J. Infect. Dis. 169:68-76; 1994.
23. Gross, P. A.; Hermogenes, A. W.; Sacks, H. S.; Lau, J.; Levandowski, R. A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. 123:518-527; 1995.
24. Nichol, K. L.; Margolis, K. L.; Wuorenma, J.; von Sternberg, T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New Engl. J. Med. 331:778-784; 1994.
25. Govaert, T. M.; Thijs, C. T.; Masurel, N.; Sprenger, M. J.; Dinant, G. J.; Knottnerus, J. A. The efficacy of influenza vaccination in elderly individuals. J. Am. Med. Assoc. 272:1661-1665; 1994.
26. Treanor, J. J.; Mattison, H. R.; Dumyati, G.; Yinnon, A. Protective efficacy of combined intranasal and inactivated influenza A virus vaccines in the elderly. Ann. Intern. Med. 117:625-633; 1992.
27. Ahmed, A.'E. H.; Nicholson, K. G.; Nguyen-Van-Tam, J. S. Reduction in mortality associated with influenza during 1989-90 epidemic. Lancet 346:591-593; 1995.